NCT01284764

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

Efficacy of a Low Volume of Water Intake and Mosapride for Endoscopy Preparation in Gastric Cancer Patients With Subtotal Gastrectomy: A Randomized Controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 144 (estimated)
• Sponsor: Inje University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.

Detailed description

We evaluate that a 500mL of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer. We plan to compare this method with routine midnight fasting method for endoscopy in patients with subtotal gastrectomy.

Conditions

• Foreign Body Left During Endoscopic Examination

Interventions

Type	Name	Description
DRUG	Mosapride	Mosapride 10mg, one dosage, once evening of the day before the endoscopy

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-07-01
• Completion: 2011-09-01
• First posted: 2011-01-27
• Last updated: 2011-10-05

Locations

1 site across 1 country: South Korea